The Safety of Infliximab Infusions in the Community Setting
BACKGROUND: Tumour necrosis factor-alpha (TNFα) has an important role in the pathogenesis of inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis and psoriasis. Infliximab, a chimeric anti-TNFα monoclonal antibody, has been shown to reduce the severity of symptom...
Saved in:
Main Authors: | James Ducharme, Cindy Pelletier, Ramesh Zacharias |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2010/138456 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long Term Safety of Infliximab
by: Thomas F Schaible
Published: (2000-01-01) -
Effectiveness and Safety of Infliximab in Two Cases of Severe Chondrocalcinosis: Nine Years of Follow-Up
by: Jácome Bruges-Armas, et al.
Published: (2014-01-01) -
Infliximab for Crohn's Disease: More Questions than Answers
by: Hugh James Freeman
Published: (2001-01-01) -
Response of Fibroblastic Rheumatism to Infliximab
by: Ricardo Romiti, et al.
Published: (2009-01-01) -
Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure
by: Georgios Aidonidis, et al.
Published: (2011-01-01)